1. Home
  2. VMO vs MGTX Comparison

VMO vs MGTX Comparison

Compare VMO & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VMO
  • MGTX
  • Stock Information
  • Founded
  • VMO 1992
  • MGTX 2015
  • Country
  • VMO United States
  • MGTX United States
  • Employees
  • VMO N/A
  • MGTX N/A
  • Industry
  • VMO Trusts Except Educational Religious and Charitable
  • MGTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VMO Finance
  • MGTX Health Care
  • Exchange
  • VMO Nasdaq
  • MGTX Nasdaq
  • Market Cap
  • VMO 652.2M
  • MGTX 670.2M
  • IPO Year
  • VMO N/A
  • MGTX N/A
  • Fundamental
  • Price
  • VMO $9.73
  • MGTX $9.25
  • Analyst Decision
  • VMO
  • MGTX Strong Buy
  • Analyst Count
  • VMO 0
  • MGTX 3
  • Target Price
  • VMO N/A
  • MGTX $25.67
  • AVG Volume (30 Days)
  • VMO 254.7K
  • MGTX 417.6K
  • Earning Date
  • VMO 01-01-0001
  • MGTX 11-12-2025
  • Dividend Yield
  • VMO 4.39%
  • MGTX N/A
  • EPS Growth
  • VMO N/A
  • MGTX N/A
  • EPS
  • VMO N/A
  • MGTX N/A
  • Revenue
  • VMO N/A
  • MGTX $37,917,000.00
  • Revenue This Year
  • VMO N/A
  • MGTX $144.79
  • Revenue Next Year
  • VMO N/A
  • MGTX $168.58
  • P/E Ratio
  • VMO N/A
  • MGTX N/A
  • Revenue Growth
  • VMO N/A
  • MGTX 366.84
  • 52 Week Low
  • VMO $7.86
  • MGTX $4.55
  • 52 Week High
  • VMO $9.87
  • MGTX $9.41
  • Technical
  • Relative Strength Index (RSI)
  • VMO 62.01
  • MGTX 65.97
  • Support Level
  • VMO $9.57
  • MGTX $7.59
  • Resistance Level
  • VMO $9.82
  • MGTX $8.56
  • Average True Range (ATR)
  • VMO 0.08
  • MGTX 0.54
  • MACD
  • VMO -0.01
  • MGTX 0.03
  • Stochastic Oscillator
  • VMO 69.33
  • MGTX 92.00

About VMO Invesco Municipal Opportunity Trust

Invesco Municipal Opportunity Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Share on Social Networks: